ANGO vs APH
AngioDynamics Inc (ANGO) versus Amphenol Corporation (APH) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Amphenol Corporation (APH) is a electronic components company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
ANGO currently screens at market cap $378.5M. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Not investment advice. Open the ANGO and APH stock pages for the full models.
Not investment advice.